Depending on the tumour context, CDK12 might contribute to the oncogenic phenotype by favouring the translation of oncogenic proteins [69], while guaranteeing genome stability by ensuring the proper translation of mitosis-related proteins [68]. This evidence concerns the gene CDK12 and neoplasm.